STOCK TITAN

ETON (NASDAQ: ETON) insider plans 1,942-share sale in Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 discloses a planned sale of restricted or control securities. The filer intends to sell 1,942 shares of common stock through Raymond James & Associates on the NASDAQ, with an aggregate market value of $30,334.04. The filing notes that 26,820,000 shares of this class were outstanding.

The securities to be sold were acquired as a grant from the issuer on 01/13/2026, with a stated amount of 6,469 shares and a cash payment date of 01/14/2026. The notice also reports that David Krempa sold 6,264 common shares on 12/12/2025 for gross proceeds of $106,460.00. By signing, the seller represents that they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ETON Form 144 filing disclose?

It discloses a planned sale of 1,942 shares of common stock with an aggregate market value of $30,334.04 under Rule 144.

Who is the broker for the planned ETON share sale?

The planned sale will be executed through Raymond James & Associates, located at 880 Carillon Parkway, St. Petersburg, FL 33716.

On which exchange are the ETON shares expected to be sold?

The Form 144 states that the common shares are expected to be sold on the NASDAQ exchange.

How many ETON shares are outstanding according to this notice?

The notice reports that there are 26,820,000 shares of the common stock class outstanding.

How and when were the ETON shares to be sold acquired?

The 6,469 common shares referenced in the acquisition table were acquired on 01/13/2026 via a grant from the issuer, with cash payment dated 01/14/2026.

What prior ETON share sales are reported in the last 3 months?

The filing reports that David Krempa sold 6,264 common shares on 12/12/2025 for gross proceeds of $106,460.00.

What representation does the seller make in this Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Eton Pharmaceuticals

NASDAQ:ETON

View ETON Stock Overview

ETON Rankings

ETON Latest News

ETON Latest SEC Filings

ETON Stock Data

450.53M
25.63M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
DEER PARK